Phenotypic analysis of chemokine-driven actin reorganization in primary human neutrophils

Assay and Drug Development Technologies

Volumn 12, Issue 2, 2014, Pages 120-128

  Kredel, Simone ^a   Wolff, Michael ^b   Gierschik, Peter ^a   Heilker, Ralf ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; F ACTIN; GROWTH RELATED ONCOGENE ALPHA PROTEIN; INTEGRIN; INTERLEUKIN 8; NAVARIXIN; PROTEIN; UNCLASSIFIED DRUG; 2-HYDROXY-N,N-DIMETHYL-3-(2-((1-(5-METHYLFURAN-2-YL)PROPYL)AMINO)-3,4-DIOXOCYCLOBUT-1-ENYLAMINO)BENZAMIDE; ACTIN; BENZAMIDE DERIVATIVE; CYCLOBUTANE DERIVATIVE;

ACTIN FILAMENT; ALGORITHM; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; IC 50; INTERNALIZATION; LEUKOCYTE ACTIVATION; MOLECULAR IMAGING; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PHENOTYPE; PROTEIN EXPRESSION; SCREENING; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ACTINS; BENZAMIDES; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINES; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUTROPHILS; PHENOTYPE;

EID: 84896325295     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2013.553     Document Type: Article

References (37)

1. Cassimeris L,McNeill H, Zigmond SH: Chemoattractant-stimulated polymorphonuclear leukocytes contain two populations of actin filaments that differ in their spatial distributions and relative stabilities. J Cell Biol 1990;110:1067-1075.
2. Hofman P, d?Andrea L, Guzman E, et al.: Neutrophil F-actin and myosin but not microtubules functionally regulate transepithelial migration induced by interleukin 8 across a cultured intestinal epithelial monolayer. Eur Cytokine Netw 1999;10:227-236. (Pubitemid 29332779)
3. Shin ME, He Y, Li D, et al.: Spatiotemporal organization, regulation, and functions of tractions during neutrophil chemotaxis. Blood 2010;116:3297-3310.
4. Gardiner EM, Pestonjamasp KN, Bohl BP. et al.: Spatial and temporal analysis of Rac activation during live neutrophil chemotaxis. Curr Biol 2002;12:2029-2034. (Pubitemid 35450926)
5. Coates TD, Watts RG, Hartman R, Howard TH: Relationship of F-actin distribution to development of polar shape in human polymorphonuclear neutrophils. J Cell Biol 1992;117:765-774.
6. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 1991;253:1278-1280. (Pubitemid 21917277)
7. Thomas KM, Pyun HY, Navarro J: Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. J Biol Chem 1990;265:20061-20064. (Pubitemid 120013971)
8. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991;253:1280-1283. (Pubitemid 21917278)
9. Allen SJ, Crown SE, Handel TM: Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007;25:787-820. (Pubitemid 46697924)
10. Bradley ME, Bond ME, Manini J, Brown Z, Charlton SJ: SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor. Br J Pharmacol 2009;158:328-338.
11. Gonsiorek W, Fan X, Hesk D, et al.: Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist. J Pharmacol Exp Ther 2007;322:477-485. (Pubitemid 47105793)
12. Murphy PM: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994;12:593-633. (Pubitemid 24140426)
13. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997;15:675-705. (Pubitemid 27169296)
14. Camps M, Carozzi A, Schnabel P, et al.: Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature 1992;360:684-686. (Pubitemid 23007685)
15. Salim JP, Goette NP, Lev PR. et al.: Dysregulation of stromal derived factor 1/ CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia. Br J Haematol 2009;144:69-77.
16. Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P: Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia- possible role of platelet activation. Thromb Haemost 2001;86:1272-1276. (Pubitemid 33064578)
17. Breland UM, Halvorsen B, Hol J, et al.: A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol 2008;28:1005-1011. (Pubitemid 351544120)
18. Watts RG, Crispens MA, Howard TH: A quantitative study of the role of F-actin in producing neutrophil shape. Cell Motil Cytoskeleton 1991;19:159-168.
19. Straczkowski M, Kowalska I, Nikolajuk A, et al.: Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol 2003;2:5.
20. Straczkowski M, Dzienis-Straczkowska S, Stepien A, et al.: Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002;87:4602-4606. (Pubitemid 35247047)
21. Lango R, Anisimowicz L, Siebert J, et al.: IL-8 concentration in coronary sinus blood during early coronary reperfusion after ischemic arrest. Eur J Cardiothorac Surg 2001;20:550-554. (Pubitemid 32743338)
22. Wolff M, Kredel S, Haasen D, et al.: High content screening of CXCR2-dependent signalling pathways. Comb Chem High Throughput Screen 2010;13:3-15.
23. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314. (Pubitemid 24046692)
24. Sekido N, Mukaida N, Harada A, et al.: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993;365:654-657. (Pubitemid 23350537)
25. Rot A: Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992;13:291-294.
26. Richardson RM, DuBose RA, Ali H, et al.: Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions. Biochemistry 1995;34:14193-14201.
27. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, Baggiolini M: The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem 1993; 268:15419-15424. (Pubitemid 23222031)
28. Wuyts A, Van ON, Haelens A, et al.: Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 1997;36:2716-2723. (Pubitemid 27106667)
29. Pike MC, Costello KM, Lamb KA: IL-8 stimulates phosphatidylinositol-4- phosphate kinase in human polymorphonuclear leukocytes. J Immunol 1992;148:3158-3164.
30. Nicholson GC, Tennant RC, Carpenter DC, et al.: A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. Pulm Pharmacol Ther 2007;20:52-59. (Pubitemid 44648801)
31. Schratl P, Heinemann A: Differential involvement of Ca2+ and actin filament in leukocyte shape change. Pharmacology 2009;83:131-140.
32. Saito H, Lai J, Rogers R, Doerschuk CM: Mechanical properties of rat bone marrow and circulating neutrophils and their responses to inflammatory mediators. Blood 2002;99:2207-2213. (Pubitemid 34525508)
33. Rose JJ, Foley JF, Murphy PM, Venkatesan S: On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2. J Biol Chem 2004;279:24372-24386. (Pubitemid 38725300)
34. Holz O, Khalilieh S, Ludwig-Sengpiel A, et al.: SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects. Eur Respir J 2010;35:564-570.
35. Rennard SI, Dale DC, Donohue JF, et al.: CXCR2 Antagonist MK-7123-A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. American Thoracic Society 2013 International Conference 2013; Philadelphia.
36. Owen C: Chemokine receptors in airway disease: which receptors to target? Pulm Pharmacol Ther 2001;14:193-202. (Pubitemid 32619924)
37. de Kruijf P, Lim HD, Roumen L, et al.: Identification of a novel allosteric binding site in the CXCR2 chemokine receptor. Mol Pharmacol 2011;80:1108-1118.